Workshop (05) – Global Drug Facility (GDF): universal access to internationally quality assured (IQA) TB commodities
Thursday, 31 October | 09:00-17:00 | Room 252A
Organized by MSH and the Global Drug Facility (GDF)
The MSH-led Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program and the GDF will share processes, practical approaches, and tools for improving TB pharmaceutical systems and services. Attendants of this workshop will learn about the best way to utilize the GDF procurement and monitoring mechanisms to shorten lead times and avoid stock-outs or wastage of TB medicines.
Post-graduate Course (08) – Data for decision-making and use of data for continuous improvement
Thursday, 31 October | 09:00-17:00 | Room 223M
Organized by MSH and KNCV
National TB Programs (NTPs) need quality data to show results and make decisions on future programmatic directions. This course provides participants with tools to use both technical and financial data for programmatic decision-making. During this interactive session, participants will examine how data can be used and interpreted for making informed decisions.
Symposium (01) – Critical issues and challenges for maximizing the impact of Xpert
Friday, 01 November | 08:00-10:00| Room Amphithéâtre Bleu
During this symposium, National TB programs will share their different strategic approaches, challenges, and financing strategies to maximize the impact of Xpert MTB/RIF. Join us to hear Alaine Nyaruhirira, from MSH Rwanda, speak on “Financing the introduction of new TB diagnostics and treatment: reflections from Rwanda and Uganda.”
Symposium (21) – Accelerating sacle-up: rapid amplification of PMDT capacity
Saturday, 02 November | 08:00-10:00 | Room Maillot
Access to MDR-TB treatment and medicines is increasing, yet many patients still go undiagnosed, or are inappropriately treated, transmitting MDR to new generations, dying. Country presentations will demonstrate ways to accelerate scale-up of programmatic management of drug-resistant TB (PMDT), systematically increasing the numbers of MDR patients diagnosed and appropriately treated.
Symposium (23) – Airborne data – opportunities for electronic health to improve tuberculosis care and lung health
Saturday, 02 November | 08:00-10:00 | Room 241
The necessity to bridge geographic and financial barriers to lung health and tuberculosis care, to improve patient outcomes, and to increase equity have resulted in increased interest in the application of e- and mHealth technologies in low- and middle-income countries. This symposium will look at examples of how such solutions benefit patient care. It aims to unite implementers, innovators,researchers and the corporate sector to synergize efforts to support sustainable technologies to the best effect.
Symposium (28) – Engaging pharmacists for TB control: rhetoric or reality?
Saturday, 02 November | 08:00-10:00 | Room 341
Private retail pharmacy outlets are increasingly seen as an ally by national TB control programs(NTPs) and the private sector market for TB regimens is substantial in some of the high-burden TB countries. In such markets especially, a significant proportion of people with presumptive TB continue to approach the pharmacist to seek care. The process of engaging private pharmacies to meet national standards of TB care is beset with hurdles. This symposium will review progress, barriers and lessons learned regarding private pharmacy engagement to TB care and control, as well as outline emerging opportunities for further expanding the role of retail pharmacies in TB control.
Symposium (31) – Rational drug use for MDR-TB: start safe, stay safe, breathe safe
Saturday, 02 November | 14:30-16:30 | Room Maillot
This symposium will describe approaches for monitoring second-line drug use to ensure patient safety, optimize treatment outcomes, and limit the amplification of resistant strains.
Symposium (53) – Improving TB case detection in Sub-Saharan African health systems: from communities to tertiary hospitals
Sunday, 03 November | 13:45-15:45 | Room 243
Low TB case detection still remains a key challenge facing TB control. The aim of this symposium is to discuss successful models to increase TB case finding and diagnosis in resource-constrained settings. Discussion will focus on sharing experiences and lessons learnt during implementation and opportunities to scale up effective program models. Join us to hear Rhehab Chimizizi, of MSH Ghana, speak on “Improving TB case detection in big hospitals and referral and teaching hospitals in Ghana,” and Habtamu Worku, of MSH Ethiopia, present “TB case detection through strengthening of the health system in Ethiopia.”